MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Amylin deposition in the brain of Parkinson’s disease patients

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…
  • 2019 International Congress

    Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease

    A. Nagy, T. Davis, T. Hassell, P. Hedera, D. Isaacs, H. Koons, F. Phibbs, S. Afrow, J. Fang (Nashville, TN, USA)

    Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…
  • 2019 International Congress

    Parkinson’s Disease Presentation in Calabar, Nigeria

    S. Oparah, U. Williams, J. Mwankon (Calabar, Nigeria)

    Objective: To create a database and describe the presentation of Parkinson's disease patients at the sole tertiary hospital in Calabar, southern Nigeria. Background: Parkinson's disease…
  • 2019 International Congress

    Unraveling biological processes implicated in MSA and PD by transcriptomic analysis

    A. Perez-Soriano, M. Arnal, D. Giraldo, M. Fernandez, T. Botta-Orfila, Y. Compta, R. Fernández-Santiago, M. Ezquerra, D. Tartaglia, MJ. Martí (Barcelona, Spain)

    Objective: To find differential biological processes between synucleinopathies (MSA and PD). Background: Multiple system atrophy (MSA) is an oligodendroglial sinucleinopathy that is often misdiagnosed as…
  • 2019 International Congress

    Braak model in Parkinson disease using MRI biomarkers

    N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, M. Mongin, C. Ewenczyk, C. Gallea, F. Gargouri, E. Bardinet, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)

    Objective: The aim of this study was to test using multimodal MRI biomarkers if the pattern of neurodegeneration in the brain of patients with PD…
  • 2019 International Congress

    A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

    M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)

    Objective: We present Lewy body disease (LBD) showing unique neuropathological findings which are widely recognized Lewy bodies (LBs) in the cerebral cortexes including the occipital…
  • 2019 International Congress

    BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

    Y. Shen, J. Wang, K. Zhang (Nanjing, China)

    Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…
  • 2019 International Congress

    Exercise and physical activity for people with Progressive Supranuclear Palsy

    S. Slade, D. Finkelstein, J. Mcginley, M. Morris (Ivanhoe, Australia)

    Objective: To (i) evaluate the literature on exercise and physical activity for Progressive Supranuclear Palsy and (ii) make PSP-specific recommendations for exercise programs and trial…
  • 2019 International Congress

    The congruence of asymmetry between motor symptoms and retinal thickness in Parkinson’s disease

    W. Suh, JY. Hong, SY. Kang (Wonju, Republic of Korea)

    Objective: To analyze the relationship between interocular difference of retinal thickness and motor asymmetry in Parkinson’s disease (PD). Background: It is known that the early…
  • 2019 International Congress

    Deep mitochondrial sequencing in Parkinson’s disease reveals possible genetic modifiers of reduced penetrance in Parkin/PINK1 mutation carriers

    J. Trinh, A. Hicks, K. Wasner, M. Farrer, F. Hentati, P. Bauer, S. Imhoff, K. Kandaswamy, N. Ouzren, M. Werber, A. Rolfs, V. Kostic, A. Lang, P. Pramstaller, P. Seibler, K. Lohmann, A. Gruenewald, C. Klein (Luebeck, Germany)

    Objective: To discover potential penetrance biomarkers in mitochondrial DNA (mtDNA) for Parkin and PINK1 mutation carriers. Background: Biallelic mutations in Parkin and PINK1 are fully…
  • « Previous Page
  • 1
  • …
  • 214
  • 215
  • 216
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24475 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley